Clinical trial
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
NCT00475605 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
- Lead sponsor
- LEO Pharma
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 25, 2005
- Completion date
- January 31, 2019
- Enrollment
- 8,071 (actual)
- Sites
- 313
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis